Is It Time To Consider Buying Danaher Corporation (NYSE:DHR)?
Let's talk about the popular Danaher Corporation ( NYSE:DHR ). The company's shares received a lot of attention from a...
The Clinical Research and Equipment industry is up 5.1% in the last week, with Danaher up 5.8%. However, the industry is down 5.9% over the past year. Looking forward, earnings are forecast to grow by 12% annually.
Has the U.S. Clinical Research and Equipment Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE |
---|---|---|---|---|
Sun, 29 May 2022 | US$773.5b | US$148.1b | US$20.1b | 31.8x |
Tue, 26 Apr 2022 | US$804.5b | US$147.3b | US$25.4b | 31.8x |
Thu, 24 Mar 2022 | US$846.7b | US$145.0b | US$25.3b | 35.2x |
Sat, 19 Feb 2022 | US$825.6b | US$144.8b | US$25.4b | 37.9x |
Mon, 17 Jan 2022 | US$878.1b | US$138.0b | US$27.3b | 39.9x |
Wed, 15 Dec 2021 | US$960.7b | US$138.0b | US$27.3b | 43.2x |
Fri, 12 Nov 2021 | US$963.1b | US$137.8b | US$27.1b | 46.1x |
Sun, 10 Oct 2021 | US$709.1b | US$105.9b | US$18.6b | 46x |
Tue, 07 Sep 2021 | US$754.5b | US$106.0b | US$18.6b | 51.2x |
Thu, 05 Aug 2021 | US$718.4b | US$105.8b | US$18.7b | 47.8x |
Sun, 09 May 2021 | US$604.0b | US$97.3b | US$17.5b | 41.2x |
Wed, 10 Feb 2021 | US$596.2b | US$89.8b | US$14.6b | 44.4x |
Tue, 03 Nov 2020 | US$465.9b | US$80.2b | US$11.9b | 38.8x |
Fri, 07 Aug 2020 | US$440.2b | US$77.2b | US$8.9b | 42.4x |
Thu, 30 Apr 2020 | US$355.0b | US$77.3b | US$8.5b | 34.3x |
Sun, 02 Feb 2020 | US$349.5b | US$76.8b | US$8.6b | 34x |
Wed, 06 Nov 2019 | US$324.1b | US$75.6b | US$7.0b | 33.3x |
Sat, 10 Aug 2019 | US$334.7b | US$76.6b | US$8.3b | 36.2x |
34.7x
How does U.S. Clinical Research and Equipment compare with similar industries?
US Market | 6.18% | |
Healthcare | 2.53% | |
Life Sciences | 5.09% | |
Clinical Research and Equipment | 5.09% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
DHR Danaher | US$266.49 | 5.8% +US$10.5b | 4.0% | PS30.7x | |
TMO Thermo Fisher Scientific | US$572.35 | 3.1% +US$6.7b | 21.9% | PS29.5x | |
IQV IQVIA Holdings | US$220.50 | 9.3% +US$3.5b | -8.2% | PS38.7x | |
ILMN Illumina | US$258.06 | 6.0% +US$2.3b | -36.4% | PS57.8x | |
MTD Mettler-Toledo International | US$1.33k | 7.1% +US$2.0b | 2.0% | PS37.9x |